Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
18.34
+1.02 (5.89%)
Oct 7, 2025, 9:37 AM EDT - Market open
Mesoblast Employees
Mesoblast had 81 employees as of June 30, 2025. The number of employees increased by 8 or 10.96% compared to the previous year.
Employees
81
Change (1Y)
8
Growth (1Y)
10.96%
Revenue / Employee
$212,321
Profits / Employee
-$1,261,012
Market Cap
2.26B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 81 | 8 | 10.96% |
| Jun 30, 2024 | 73 | -10 | -12.05% |
| Jun 30, 2023 | 83 | 6 | 7.79% |
| Jun 30, 2022 | 77 | -6 | -7.23% |
| Jun 30, 2021 | 83 | -19 | -18.63% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MESO News
- 14 hours ago - Ryoncil® Revenues Increase 66% in Second Quarter Post Launch - GlobeNewsWire
- 1 day ago - Quantum Computing, Mesoblast And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 4 days ago - Ryoncil® Receives J-Code From Medicare & Medicaid Services (CMS) Facilitating Reimbursement and Broader Patient Access - GlobeNewsWire
- 11 days ago - Mesoblast Cell Therapy Products are Designated U.S. Origin and Not Subject to Tariffs - GlobeNewsWire
- 22 days ago - Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences - GlobeNewsWire
- 4 weeks ago - Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes - GlobeNewsWire
- 5 weeks ago - Mesoblast Limited (MESO) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Banner Year for Mesoblast With First FDA Product Approval and Successful Commercial Launch of Ryoncil® - GlobeNewsWire